(20S)-ginsenoside Rg3 increases expression ISO RGD:733669 6480464 ginsenoside Rg3 results in increased expression of MAP2 mRNA CTD PMID:24599032 (S)-3,5-dihydroxyphenylglycine increases phosphorylation EXP 6480464 3, 5-dihydroxyphenylglycine results in increased phosphorylation of MAP2 protein CTD PMID:15893642 (S)-3,5-dihydroxyphenylglycine multiple interactions EXP 6480464 [3 more ... CTD PMID:15893642 (S)-colchicine decreases expression ISO RGD:733668 6480464 Colchicine results in decreased expression of MAP2 mRNA CTD PMID:34748853 1,1-dichloroethene decreases expression ISO RGD:733669 6480464 vinylidene chloride results in decreased expression of MAP2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:733669 6480464 1, 2-Dimethylhydrazine results in decreased expression of MAP2 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:733669 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:733669 6480464 Ethinyl Estradiol results in increased expression of MAP2 mRNA CTD PMID:14976129 17beta-estradiol multiple interactions ISO RGD:733668 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP2 mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733668 6480464 Dihydrotestosterone results in increased expression of MAP2 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:733669 6480464 2 more ... CTD PMID:34627992 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733669 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733669 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Tretinoin results in increased expression of MAP2 mRNA] CTD PMID:34627992 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,5-hexanedione decreases expression EXP 6480464 2, 5-hexanedione results in decreased expression of MAP2 protein modified form CTD PMID:20554699 2-hydroxypropanoic acid decreases expression ISO RGD:733668 6480464 Lactic Acid results in decreased expression of MAP2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:733668 6480464 beta-methylcholine affects the expression of MAP2 mRNA CTD PMID:21179406 3',5'-cyclic AMP multiple interactions ISO RGD:733668 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of MAP2 protein CTD PMID:33713149 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of MAP2 mRNA CTD PMID:27914987 3,4-methylenedioxymethamphetamine increases expression ISO RGD:733669 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MAP2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733668 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of MAP2 mRNA CTD PMID:29698629 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] CTD PMID:26676567 5-fluorouracil increases expression ISO RGD:733668 6480464 Fluorouracil results in increased expression of MAP2 mRNA CTD PMID:16510598 9-cis-retinoic acid increases expression ISO RGD:733668 6480464 Alitretinoin results in increased expression of MAP2 protein CTD PMID:23500671 9-cis-retinoic acid decreases expression ISO RGD:733668 6480464 Alitretinoin results in decreased expression of MAP2 mRNA, Alitretinoin results in decreased expression of MAP2 protein CTD PMID:36805303 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MAP2 protein CTD PMID:29524570 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAP2 protein CTD PMID:30096436 acrylamide multiple interactions EXP 6480464 calpeptin inhibits the reaction [Acrylamide results in decreased expression of MAP2 protein], calpeptin inhibits the reaction [Acrylamide results in increased expression of MAP2 protein] CTD PMID:29524570 , PMID:30096436 aflatoxin B1 decreases methylation ISO RGD:733668 6480464 Aflatoxin B1 results in decreased methylation of MAP2 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:733668 6480464 Aflatoxin B1 results in decreased expression of MAP2 mRNA CTD PMID:34748853 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MAP2 mRNA CTD PMID:33354967 agomelatine multiple interactions EXP 6480464 agomelatine results in increased expression of and results in increased phosphorylation of MAP2 protein CTD PMID:22160164 aldicarb multiple interactions ISO RGD:733668 6480464 Aldicarb promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 all-trans-retinoic acid multiple interactions ISO RGD:733668 6480464 [NTF3 protein co-treated with Tretinoin] results in increased expression of MAP2 protein more ... CTD PMID:16996685 more ... all-trans-retinoic acid affects expression ISO RGD:733668 6480464 Tretinoin affects the expression of MAP2 protein CTD PMID:35594436 all-trans-retinoic acid multiple interactions ISO RGD:733669 6480464 2 more ... CTD PMID:34627992 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of MAP2 mRNA CTD PMID:24977338 all-trans-retinoic acid decreases expression ISO RGD:733668 6480464 Tretinoin results in decreased expression of MAP2 mRNA, Tretinoin results in decreased expression of MAP2 protein CTD PMID:21934132 , PMID:36805303 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of MAP2 protein CTD PMID:16944780 , PMID:17130476 all-trans-retinoic acid increases expression ISO RGD:733669 6480464 Tretinoin results in increased expression of MAP2 mRNA, Tretinoin results in increased expression of MAP2 protein CTD PMID:16424397 , PMID:34627992 all-trans-retinoic acid increases expression ISO RGD:733668 6480464 Tretinoin results in increased expression of MAP2 mRNA, Tretinoin results in increased expression of MAP2 protein CTD PMID:15464216 more ... aluminium sulfate (anhydrous) multiple interactions EXP 6480464 aluminum sulfate inhibits the reaction [Excitatory Amino Acid Agents results in increased metabolism of MAP2 protein] CTD PMID:10428068 amantadine decreases expression ISO RGD:733668 6480464 Amantadine results in decreased expression of MAP2 mRNA CTD PMID:34748853 ammonia multiple interactions EXP 6480464 Ammonia inhibits the reaction [1-amino-1 more ... CTD PMID:15893642 ammonia increases phosphorylation EXP 6480464 Ammonia results in increased phosphorylation of MAP2 protein CTD PMID:15893642 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP2 mRNA CTD PMID:16483693 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of MAP2 protein CTD PMID:16483693 antimycin A decreases expression ISO RGD:733668 6480464 Antimycin A results in decreased expression of MAP2 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO RGD:733668 6480464 Antirheumatic Agents results in increased expression of MAP2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:733668 6480464 aristolochic acid I results in decreased expression of MAP2 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:733669 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MAP2 protein CTD PMID:22013134 arsane affects methylation ISO RGD:733668 6480464 Arsenic affects the methylation of MAP2 gene CTD PMID:25304211 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAP2 protein CTD PMID:35993674 arsane decreases expression ISO RGD:733669 6480464 Arsenic results in decreased expression of MAP2 mRNA CTD PMID:24019935 arsenic atom affects methylation ISO RGD:733668 6480464 Arsenic affects the methylation of MAP2 gene CTD PMID:25304211 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAP2 protein CTD PMID:35993674 arsenic atom decreases expression ISO RGD:733669 6480464 Arsenic results in decreased expression of MAP2 mRNA CTD PMID:24019935 arsenous acid decreases expression ISO RGD:733668 6480464 Arsenic Trioxide results in decreased expression of MAP2 protein CTD PMID:15894607 azoxystrobin decreases expression ISO RGD:733668 6480464 azoxystrobin results in decreased expression of MAP2 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO RGD:733669 6480464 Benzo(a)pyrene results in decreased expression of MAP2 mRNA CTD PMID:20713471 benzo[a]pyrene affects methylation ISO RGD:733668 6480464 Benzo(a)pyrene affects the methylation of MAP2 5' UTR, Benzo(a)pyrene affects the methylation of MAP2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:733669 6480464 Benzo(a)pyrene results in increased expression of MAP2 mRNA CTD PMID:22610609 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAP2 protein CTD PMID:21467743 Benzo[k]fluoranthene decreases expression ISO RGD:733669 6480464 benzo(k)fluoranthene results in decreased expression of MAP2 mRNA CTD PMID:26377693 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of MAP2 mRNA CTD PMID:16648578 bisphenol A decreases expression ISO RGD:733669 6480464 bisphenol A results in decreased expression of MAP2 mRNA, bisphenol A results in decreased expression of MAP2 protein CTD PMID:32156529 , PMID:32512148 bisphenol A increases methylation ISO RGD:733668 6480464 bisphenol A results in increased methylation of MAP2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:733668 6480464 bisphenol A results in decreased expression of MAP2 mRNA, bisphenol A results in decreased expression of MAP2 protein CTD PMID:20678512 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP2 mRNA CTD PMID:25181051 bucladesine multiple interactions ISO RGD:733668 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of MAP2 mRNA CTD PMID:29698629 butanal decreases expression ISO RGD:733668 6480464 butyraldehyde results in decreased expression of MAP2 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:733668 6480464 Cadmium results in increased expression of MAP2 mRNA CTD PMID:21172416 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of MAP2 mRNA CTD PMID:17293106 Calpeptin multiple interactions EXP 6480464 calpeptin inhibits the reaction [Acrylamide results in decreased expression of MAP2 protein], calpeptin inhibits the reaction [Acrylamide results in increased expression of MAP2 protein] CTD PMID:29524570 , PMID:30096436 capsaicin increases expression ISO RGD:733668 6480464 Capsaicin results in increased expression of MAP2 mRNA CTD PMID:18405923 carbaryl multiple interactions ISO RGD:733668 6480464 Carbaryl promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 CGP 52608 multiple interactions ISO RGD:733668 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP2 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:733669 6480464 Chlordecone results in increased expression of MAP2 mRNA CTD PMID:33711761 chlorohydrocarbon decreases expression EXP 6480464 Hydrocarbons, Chlorinated results in decreased expression of MAP2 mRNA CTD PMID:22872703 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] CTD PMID:26676567 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of MAP2 mRNA CTD PMID:15079866 chlorpyrifos decreases expression ISO RGD:733669 6480464 Chlorpyrifos results in decreased expression of MAP2 mRNA CTD PMID:20350560 chlorpyrifos increases expression ISO RGD:733669 6480464 Chlorpyrifos results in increased expression of MAP2 protein CTD PMID:26018426 choline multiple interactions ISO RGD:733669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP2 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP2 mRNA CTD PMID:22023808 cisplatin decreases expression ISO RGD:733668 6480464 Cisplatin results in decreased expression of MAP2 mRNA CTD PMID:27392435 clobetasol decreases expression ISO RGD:733669 6480464 Clobetasol results in decreased expression of MAP2 mRNA CTD PMID:27462272 cobalt dichloride increases expression ISO RGD:733669 6480464 cobaltous chloride results in increased expression of MAP2 protein CTD PMID:16772336 cocaine affects expression EXP 6480464 Cocaine affects the expression of MAP2 mRNA CTD PMID:20187946 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of MAP2 mRNA CTD PMID:16076954 colforsin daropate hydrochloride increases expression ISO RGD:733668 6480464 Colforsin results in increased expression of MAP2 protein CTD PMID:34897981 copper atom multiple interactions ISO RGD:733668 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAP2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:733668 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAP2 mRNA CTD PMID:20971185 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of MAP2 mRNA CTD PMID:26577399 Cyclopamine multiple interactions EXP 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of MAP2 protein] CTD PMID:24464877 cyclosporin A increases expression ISO RGD:733668 6480464 Cyclosporine results in increased expression of MAP2 mRNA CTD PMID:20106945 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of MAP2 mRNA CTD PMID:22528246 cyproconazole increases expression ISO RGD:733669 6480464 cyproconazole results in increased expression of MAP2 mRNA CTD PMID:22045034 cytarabine decreases expression ISO RGD:733668 6480464 Cytarabine results in decreased expression of MAP2 protein CTD PMID:21198554 cytarabine increases expression ISO RGD:733668 6480464 Cytarabine results in increased expression of MAP2 mRNA CTD PMID:21198554 DAPT multiple interactions ISO RGD:733669 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA] CTD PMID:24929042 DDT decreases expression EXP 6480464 DDT results in decreased expression of MAP2 mRNA CTD PMID:30207508 deguelin decreases expression ISO RGD:733668 6480464 deguelin results in decreased expression of MAP2 mRNA CTD PMID:33512557 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MAP2 protein CTD PMID:11311531 diarsenic trioxide decreases expression ISO RGD:733668 6480464 Arsenic Trioxide results in decreased expression of MAP2 protein CTD PMID:15894607 dibutyl phthalate increases expression ISO RGD:733669 6480464 Dibutyl Phthalate results in increased expression of MAP2 mRNA CTD PMID:21266533 dichlorvos multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Dichlorvos results in increased phosphorylation of MAP2 protein] CTD PMID:16635102 dichlorvos increases phosphorylation EXP 6480464 Dichlorvos results in increased phosphorylation of MAP2 protein CTD PMID:11282359 , PMID:16635102 dieldrin multiple interactions ISO RGD:733668 6480464 Dieldrin promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 dihydrolipoic acid multiple interactions ISO RGD:733669 6480464 dihydrolipoic acid inhibits the reaction [NGF protein results in increased expression of MAP2 protein] CTD PMID:21462292 diquat increases expression ISO RGD:733668 6480464 Diquat results in increased expression of MAP2 mRNA CTD PMID:21172416 diuron increases expression EXP 6480464 Diuron results in increased expression of MAP2 mRNA CTD PMID:25152437 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MAP2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733668 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733668 6480464 Doxorubicin results in decreased expression of MAP2 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:733668 6480464 Doxorubicin results in increased expression of MAP2 mRNA CTD PMID:30031762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP2 mRNA CTD PMID:29391264 enzalutamide decreases expression ISO RGD:733668 6480464 enzalutamide results in decreased expression of MAP2 mRNA CTD PMID:29581250 enzalutamide multiple interactions ISO RGD:733668 6480464 KDM1A protein promotes the reaction [enzalutamide results in decreased expression of MAP2 mRNA] CTD PMID:29581250 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of MAP2 protein CTD PMID:20829428 ethanol decreases expression ISO RGD:733669 6480464 Ethanol results in decreased expression of MAP2 protein CTD PMID:23500890 ethanol multiple interactions ISO RGD:733669 6480464 Ethanol affects the expression of and affects the splicing of MAP2 mRNA, TLR4 gene mutant form inhibits the reaction [Ethanol results in decreased expression of MAP2 protein] CTD PMID:23500890 , PMID:30319688 folic acid multiple interactions ISO RGD:733669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP2 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:733669 6480464 Folic Acid results in decreased expression of MAP2 mRNA CTD PMID:25629700 gamma-hexachlorocyclohexane multiple interactions ISO RGD:733668 6480464 Hexachlorocyclohexane promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP2 mRNA CTD PMID:33387578 ginsenoside Rb1 increases expression ISO RGD:733669 6480464 ginsenoside Rb1 results in increased expression of MAP2 mRNA CTD PMID:24599032 ginsenoside Rd increases expression ISO RGD:733669 6480464 ginsenoside Rd results in increased expression of MAP2 mRNA, ginsenoside Rd results in increased expression of MAP2 protein CTD PMID:24599032 ginsenoside Re increases expression ISO RGD:733669 6480464 ginsenoside Re results in increased expression of MAP2 mRNA, ginsenoside Re results in increased expression of MAP2 protein CTD PMID:24599032 ginsenoside Rg1 increases expression ISO RGD:733669 6480464 ginsenoside Rg1 results in increased expression of MAP2 mRNA CTD PMID:24599032 glutathione multiple interactions ISO RGD:733668 6480464 Glutathione inhibits the reaction [Particulate Matter results in decreased expression of MAP2 mRNA] CTD PMID:28153600 glyphosate increases expression ISO RGD:733668 6480464 glyphosate results in increased expression of MAP2 mRNA, glyphosate results in increased expression of MAP2 protein CTD PMID:35485992 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of MAP2 mRNA CTD PMID:15079866 heptachlor multiple interactions ISO RGD:733668 6480464 Heptachlor promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 hexachlorophene multiple interactions ISO RGD:733668 6480464 Hexachlorophene inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 hydrogen peroxide affects expression ISO RGD:733668 6480464 Hydrogen Peroxide affects the expression of MAP2 protein CTD PMID:21179406 isoniazide affects expression ISO RGD:733669 6480464 Isoniazid affects the expression of MAP2 mRNA CTD PMID:22131109 ivermectin decreases expression ISO RGD:733668 6480464 Ivermectin results in decreased expression of MAP2 protein CTD PMID:32959892 kainic acid multiple interactions ISO RGD:733669 6480464 PTGS2 affects the reaction [Kainic Acid results in increased expression of MAP2 mRNA] CTD PMID:21589914 kainic acid increases expression ISO RGD:733669 6480464 Kainic Acid results in increased expression of MAP2 mRNA CTD PMID:21589914 L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of MAP2 protein CTD PMID:15372504 L-ascorbic acid multiple interactions ISO RGD:733668 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in increased expression of MAP2 protein CTD PMID:33713149 L-methionine multiple interactions ISO RGD:733669 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP2 mRNA CTD PMID:20938992 lead diacetate decreases expression ISO RGD:733669 6480464 lead acetate results in decreased expression of MAP2 mRNA CTD PMID:22013134 leflunomide decreases expression ISO RGD:733668 6480464 leflunomide results in decreased expression of MAP2 mRNA CTD PMID:28988120 LY294002 decreases expression ISO RGD:733669 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MAP2 protein CTD PMID:29129800 maneb multiple interactions ISO RGD:733669 6480464 [Maneb co-treated with Paraquat] results in decreased expression of MAP2 mRNA more ... CTD PMID:23963992 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of MAP2 mRNA CTD PMID:28801915 melatonin multiple interactions ISO RGD:733669 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of MAP2 mRNA] CTD PMID:23963992 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of MAP2 mRNA, Methamphetamine results in decreased expression of MAP2 protein CTD PMID:17407499 methotrexate increases expression ISO RGD:733668 6480464 Methotrexate results in increased expression of MAP2 mRNA CTD PMID:24449571 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of MAP2 gene CTD PMID:35440735 methylmercury chloride decreases expression ISO RGD:733669 6480464 methylmercuric chloride results in decreased expression of MAP2 mRNA CTD PMID:21385734 , PMID:22555245 methylmercury chloride increases expression ISO RGD:733668 6480464 methylmercuric chloride results in increased expression of MAP2 mRNA CTD PMID:23179753 methylmercury chloride decreases expression ISO RGD:733668 6480464 methylmercuric chloride results in decreased expression of MAP2 mRNA CTD PMID:22555245 miconazole decreases expression ISO RGD:733669 6480464 Miconazole results in decreased expression of MAP2 mRNA CTD PMID:27462272 morphine decreases expression EXP 6480464 Morphine results in decreased expression of MAP2 mRNA CTD PMID:15183518 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in decreased expression of MAP2 protein CTD PMID:11681848 N,N-diethyl-m-toluamide decreases expression EXP 6480464 DEET results in decreased expression of MAP2 protein CTD PMID:11681848 N-acetyl-L-cysteine multiple interactions ISO RGD:733669 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:28499986 N-acetyl-L-cysteine multiple interactions ISO RGD:733668 6480464 Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MAP2 mRNA] CTD PMID:28153600 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of MAP2 mRNA CTD PMID:19638242 nickel dichloride multiple interactions ISO RGD:733668 6480464 nickel chloride promotes the reaction [Tretinoin results in increased expression of MAP2 mRNA] CTD PMID:25614230 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of MAP2 mRNA CTD PMID:20303128 nimodipine multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Dichlorvos results in increased phosphorylation of MAP2 protein] CTD PMID:16635102 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of MAP2 mRNA CTD PMID:33484710 Nivalenol increases expression ISO RGD:733669 6480464 nivalenol results in increased expression of MAP2 mRNA CTD PMID:35016910 olanzapine increases expression EXP 6480464 olanzapine results in increased expression of MAP2 mRNA CTD PMID:15079866 oxaliplatin increases expression ISO RGD:733668 6480464 oxaliplatin results in increased expression of MAP2 mRNA CTD PMID:16510598 ozone multiple interactions ISO RGD:733669 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MAP2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAP2 mRNA CTD PMID:34911549 panobinostat increases expression ISO RGD:733668 6480464 panobinostat results in increased expression of MAP2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:733668 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP2 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:733668 6480464 Acetaminophen results in increased expression of MAP2 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP2 mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:733669 6480464 [Maneb co-treated with Paraquat] results in decreased expression of MAP2 mRNA more ... CTD PMID:23963992 PD123319 multiple interactions EXP 6480464 PD 123319 inhibits the reaction [AGT protein results in increased expression of MAP2 protein] CTD PMID:17068200 permethrin multiple interactions EXP 6480464 [DEET co-treated with Permethrin] results in decreased expression of MAP2 protein CTD PMID:11681848 permethrin decreases expression EXP 6480464 Permethrin results in decreased expression of MAP2 protein CTD PMID:11681848 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of MAP2 mRNA CTD PMID:17616710 phenylmercury acetate increases expression ISO RGD:733668 6480464 Phenylmercuric Acetate results in increased expression of MAP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733668 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP2 mRNA CTD PMID:27188386 physostigmine multiple interactions ISO RGD:733669 6480464 Physostigmine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:28499986 picoxystrobin decreases expression ISO RGD:733668 6480464 picoxystrobin results in decreased expression of MAP2 mRNA CTD PMID:33512557 poly(vinylpyrrolidone) multiple interactions ISO RGD:733669 6480464 [Silver Compounds co-treated with Povidone] results in decreased expression of MAP2 protein CTD PMID:35697184 potassium chromate decreases expression ISO RGD:733668 6480464 potassium chromate(VI) results in decreased expression of MAP2 mRNA CTD PMID:22714537 potassium dichromate decreases expression ISO RGD:733669 6480464 Potassium Dichromate results in decreased expression of MAP2 mRNA CTD PMID:23608068 progesterone increases expression ISO RGD:733668 6480464 Progesterone results in increased expression of MAP2 mRNA CTD PMID:18037150 progesterone decreases expression ISO RGD:733668 6480464 Progesterone results in decreased expression of MAP2 mRNA CTD PMID:21795739 progesterone increases expression EXP 6480464 Progesterone results in increased expression of MAP2 protein CTD PMID:16054770 pyrimidifen decreases expression ISO RGD:733668 6480464 pyrimidifen results in decreased expression of MAP2 mRNA CTD PMID:33512557 pyrroloquinoline quinone decreases expression ISO RGD:733668 6480464 PQQ Cofactor results in decreased expression of MAP2 mRNA CTD PMID:28578007 rac-lactic acid decreases expression ISO RGD:733668 6480464 Lactic Acid results in decreased expression of MAP2 mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MAP2 protein CTD PMID:24464877 resveratrol multiple interactions EXP 6480464 cyclopamine inhibits the reaction [resveratrol results in increased expression of MAP2 protein] CTD PMID:24464877 risperidone increases expression EXP 6480464 Risperidone results in increased expression of MAP2 mRNA CTD PMID:15079866 rotenone multiple interactions ISO RGD:733668 6480464 Rotenone inhibits the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAP2 mRNA CTD PMID:32481507 rotenone decreases expression ISO RGD:733668 6480464 Rotenone results in decreased expression of MAP2 mRNA CTD PMID:33512557 Salidroside increases expression ISO RGD:733669 6480464 rhodioloside results in increased expression of MAP2 mRNA, rhodioloside results in increased expression of MAP2 protein CTD PMID:24929042 Salidroside multiple interactions ISO RGD:733669 6480464 N-(N-(3 more ... CTD PMID:24929042 sarin decreases expression EXP 6480464 Sarin results in decreased expression of MAP2 protein CTD PMID:27639427 SB 431542 multiple interactions ISO RGD:733668 6480464 [4-(5-benzo(1 more ... CTD PMID:27188386 more ... scopolamine decreases expression ISO RGD:733668 6480464 Scopolamine results in decreased expression of MAP2 protein CTD PMID:22096544 scopolamine multiple interactions ISO RGD:733668 6480464 Ashwagandha inhibits the reaction [Scopolamine results in decreased expression of MAP2 protein], withanone inhibits the reaction [Scopolamine results in decreased expression of MAP2 protein] CTD PMID:22096544 sevoflurane multiple interactions ISO RGD:733669 6480464 APOE protein alternative form inhibits the reaction [Sevoflurane results in increased expression of MAP2 protein] CTD PMID:35575159 sevoflurane increases expression ISO RGD:733669 6480464 Sevoflurane results in increased expression of MAP2 protein CTD PMID:35575159 silver atom decreases expression ISO RGD:733668 6480464 Silver results in decreased expression of MAP2 protein CTD PMID:27593553 silver(0) decreases expression ISO RGD:733668 6480464 Silver results in decreased expression of MAP2 protein CTD PMID:27593553 silver(1+) nitrate decreases expression ISO RGD:733669 6480464 Silver Nitrate results in decreased expression of MAP2 protein CTD PMID:35697184 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of MAP2 protein CTD PMID:26676567 sirolimus multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein], Chloroquine inhibits the reaction [Sirolimus results in increased expression of MAP2 protein] CTD PMID:26676567 sodium arsenate decreases expression ISO RGD:733669 6480464 sodium arsenate results in decreased expression of MAP2 mRNA CTD PMID:22131109 sodium arsenite increases expression ISO RGD:733668 6480464 sodium arsenite results in increased expression of MAP2 mRNA CTD PMID:22714537 sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAP2 protein CTD PMID:35993674 sodium arsenite decreases expression ISO RGD:733668 6480464 sodium arsenite results in decreased expression of MAP2 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:733669 6480464 sodium arsenite results in decreased expression of MAP2 mRNA CTD PMID:22131109 streptozocin multiple interactions ISO RGD:733669 6480464 Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein], Physostigmine inhibits the reaction [Streptozocin results in decreased expression of MAP2 protein] CTD PMID:28499986 streptozocin decreases expression ISO RGD:733669 6480464 Streptozocin results in decreased expression of MAP2 protein CTD PMID:28499986 sulforaphane increases expression ISO RGD:733668 6480464 sulforaphane results in increased expression of MAP2 mRNA CTD PMID:31838189 tetrachloromethane affects expression ISO RGD:733669 6480464 Carbon Tetrachloride affects the expression of MAP2 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAP2 mRNA CTD PMID:33387578 thifluzamide decreases expression ISO RGD:733668 6480464 thifluzamide results in decreased expression of MAP2 mRNA CTD PMID:33512557 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MAP2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:733668 6480464 trichostatin A results in increased expression of MAP2 mRNA CTD PMID:24935251 trichostatin A affects expression ISO RGD:733668 6480464 trichostatin A affects the expression of MAP2 mRNA CTD PMID:28542535 triclosan decreases expression ISO RGD:733668 6480464 Triclosan results in decreased expression of MAP2 mRNA CTD PMID:30510588 triphenyl phosphate decreases expression ISO RGD:733669 6480464 triphenyl phosphate results in decreased expression of MAP2 mRNA CTD PMID:35752650 triptonide decreases expression ISO RGD:733669 6480464 triptonide results in decreased expression of MAP2 mRNA CTD PMID:33045310 Tryptanthrine increases expression ISO RGD:733668 6480464 tryptanthrine results in increased expression of MAP2 protein CTD PMID:23500671 valproic acid increases expression ISO RGD:733669 6480464 Valproic Acid results in increased expression of MAP2 mRNA CTD PMID:22045034 valproic acid decreases expression ISO RGD:733668 6480464 Valproic Acid results in decreased expression of MAP2 mRNA CTD PMID:34742744 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of MAP2 mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of MAP2 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:733669 6480464 Valproic Acid results in decreased expression of MAP2 mRNA CTD PMID:22131109 valproic acid multiple interactions ISO RGD:733668 6480464 Valproic Acid promotes the reaction [[4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] CTD PMID:32949729 valproic acid affects expression ISO RGD:733669 6480464 Valproic Acid affects the expression of MAP2 mRNA CTD PMID:26072468 valproic acid increases expression ISO RGD:733668 6480464 Valproic Acid results in increased expression of MAP2, Valproic Acid results in increased expression of MAP2 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO RGD:733668 6480464 Valproic Acid affects the expression of MAP2 mRNA CTD PMID:25979313 , PMID:26072468 valsartan multiple interactions EXP 6480464 Valsartan promotes the reaction [AGT protein results in increased expression of MAP2 protein] CTD PMID:17068200 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of MAP2 mRNA CTD PMID:25423262 WIN 55212-2 decreases expression ISO RGD:733669 6480464 (3R)-((2 more ... CTD PMID:12237329 zoledronic acid decreases expression ISO RGD:733668 6480464 zoledronic acid results in decreased expression of MAP2 mRNA CTD PMID:24714768
